Question 1

Does Invesco own MCRB stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Invesco holds 12,974 shares of MCRB (Seres Therapeutics), worth $102,365.

Question 2

How many shares of MCRB does Invesco own?

Accepted Answer

As of its Q2 2026 13F, Invesco holds 12,974 shares of MCRB (Seres Therapeutics).

Question 3

What is Invesco's MCRB position worth?

Accepted Answer

As of its Q2 2026 13F, Invesco's MCRB position is worth $102,365.

Question 4

Is Invesco buying or selling MCRB?

Accepted Answer

In Q2 2026, Invesco reduced its MCRB position by 1,573 shares (-10.8%).

Question 5

When did Invesco first buy MCRB?

Accepted Answer

Invesco first reported MCRB in its Q3 2025 13F and has listed it in 4 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	12,974	-10.8%	$102,365	0.0%	$7.89	0
2026-Q1	Increased	14,547	+1.3%	$129,032	0.0%	$8.80	15
2025-Q4	Increased	14,360	+37.5%	$213,677	0.0%	$14.44	20
2025-Q3	New	10,442	-	$200,904	0.0%	$18.69	35

MCRB4 quarters

MCRB
4 quarters